Articles

  • 1 day ago | diagnosticimaging.com | Jeff Hall

    While traditional non-adaptive radiotherapy for glioblastomas has reportedly yielded an approximate 11 percent rate of marginal failure, recently presented findings from the UNITED trial revealed that magnetic resonance imaging (MRI)-guided radiation reduced the marginal failure rate to 4.1 percent.

  • 2 days ago | diagnosticimaging.com | Jeff Hall

    With the launch of the T-Mode™ Anterior Knee feature on its handheld musculoskeletal ultrasound scanners, Clarius Mobile Health seeks to illuminate the subtleties of anterior knee examination for novice ultrasound users.

  • 2 days ago | diagnosticimaging.com | Jeff Hall

    An emerging deep learning model, which employs generative adversarial network architecture to obtain synthesized high-field-strength magnetic resonance imaging (MRI) views from low-field strength MRI inputs, may facilitate portable MRI assessment of patients with multiple sclerosis (MS).

  • 2 days ago | diagnosticimaging.com | Jeff Hall

    Multivariable analysis from a new study demonstrates that the computed tomography (CT)-based coronary artery calcium (CAC) score offers better preoperative prognostic capability than coronary artery stenosis severity or the CT-based fractional flow reserve (CT-FFR) for predicting long-term survival in elderly patients with lung cancer who undergo surgery.

  • 3 days ago | diagnosticimaging.com | Jeff Hall

    The statistics on colon cancer continue to be troubling. Colorectal cancer (CTC) is reportedly the third leading cause of death among African Americans, and there has been an increasing incidence of CTC among people under the age of 50.1,2 In a recently published study in JAMA Network Open, researchers noted increasing annual incidence rates of colorectal adenocarcinoma among people 15 to 50 years of age.2In a recent interview.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →